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SUMMARY
BACKGROUND AND OBJECTIVES: Chronic pos-
toperative pain (CPOP) prevalence is high, and is mani-
fested both after minor and major surgeries. This subject 
has been increasingly studied. This study aimed at de-
scribing major aspects of this syndrome. 
CONTENTS: CPOP mechanisms, risk factors for its de-
velopment, prevention and pain treatments are described. 
CONCLUSION: CPOP impacts patients’ quality of life, 
is difficult to treat and the best approach is to prevent it. 
With a better understanding of pathophysiological bases 
for perpetuation of pain after a surgical procedure and of 
risk factors, new treatment options are appearing. The real 
benefits of preventive drugs are being increasingly stud-
ied. To prevent pain, surgical teams and patients have to 
be aware of the risks of each procedure, not only in the 
immediate postoperative period but also in the long run. 
Keywords: Chronic pain, Postoperative period, Preven-
tion, Risk factors.
RESUMO
JUSTIFICATIVA E OBJETIVOS: A prevalência da 
dor crônica pós-operatória (DCPO) é grande, acom-
etendo tanto cirurgias de pequeno porte como as de 
Chronic postoperative pain: pathophysiology, risk factors and  
prevention*
Dor crônica pós-operatória: fisiopatologia, fatores de risco e prevenção
Eduardo Jun Sadatsune1, Plínio da Cunha Leal1, Jefferson Clivatti2, Rioko Kimiko Sakata3
*Received from the Anesthesiology, Pain and Intensive Care Department, Federal University of São Paulo 
(UNIFESP). São Paulo, SP.
1. Third year Resident in Anesthesiology, Federal University 
of São Paulo (UNIFESP). São Paulo, SP, Brazil.
2. Professor of Anesthesiology, Federal University of São 
Paulo (UNIFESP). São Paulo, SP, Brazil.
3. Associate Professor and Coordinator of the Pain Sector, 
Federal University of São Paulo (UNIFESP). São Paulo, SP, 
Brazil.
Correspondence to:
Rioko Kimiko Sakata, MD
Rua Três de Maio 61/51 – Vila Clementino
04044-020 São Paulo, SP.
Fone: 55 (11) 5576-4069
E-mail: riokoks.dcir@epm.br
grande porte. Esse tema vem sendo estudado cada vez 
mais. O objetivo deste estudo foi descrever aspectos im-
portantes sobre essa síndrome.
CONTEÚDO: Descrevem-se os mecanismos da DCPO, 
os fatores de risco para seu desenvolvimento, a preven-
ção e o tratamento da dor.
CONCLUSÃO: A DCPO afeta a qualidade de vida dos 
pacientes, é de difícil tratamento sendo a medida mais ef-
icaz a sua prevenção. Com o melhor entendimento das 
bases fisiopatológicas da perpetuação da dor após um pro-
cedimento cirúrgico e dos fatores de risco, novas opções 
para o seu tratamento estão surgindo. Os reais benefícios 
da utilização de fármacos usados de forma preventiva 
estão sendo cada vez mais estudados. Na prevenção da 
dor as equipes cirúrgicas e os pacientes necessitam estar 
atentos aos riscos de cada procedimento, não somente no 
perioperatório imediato, mas também em longo prazo.
Descritores: Dor crônica, Fatores de riscos, Pós-opera-
tório, Prevenção.
INTRODUCTION
Chronic postoperative pain (CPOP) has been neglected for 
a long time by the medical community. Currently, CPOP is 
being increasingly studied with important evolution.
Although scarcely documented in the literature, CPOP 
incidence is highly variable and appears both after high-
ly complex surgeries, such as thoracotomy, and after 
simplest ones, such as inguinal hernia and vasectomy. 
After surgery, between 5% and 80% of patients evolve to 
chronic pain, especially after procedures causing nerv-
ous injury1. The incidence after limb amputation is from 
30% to 81%; after thoracotomy and inguinal hernia, 
from 11.5% to 47%; after cholecystectomy from 3% to 
56%2; after breast cancer surgery from 10% to 50%2,3; 
after vasectomy 15%4; after C-section from 6% to 18% 
and after vaginal delivery from 4% to 10%5.
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The broad variation of incidence may be associated to 
several definitions used for CPOP in different studies6,7. 
Macrae defines CPOP as pain after surgical procedure 
lasting for at least two months, unrelated to pre-existing 
pain and without other defined causes (such as, for ex-
ample, infection)8. Other causes for such variability in 
the incidence of CPOP are evaluation and interpretation 
of types of painful syndromes and different study de-
signs7. Chart 1 describes some examples of CPOP.
Chart 1- Examples of surgical procedures and evolution to chronic pain
Limb amputation Stump pain, phantom limb pain, myofascial pain
Thoracotomy Intercostal neuritis, myofascial syndrome, costochondritis
Mastectomy Traumatic neuritis, myofascial syndrome, frozen shoulder, lymphedema
Spine Arachnoiditis, myofascial syndrome
Myocardial revascularization Traumatic neuritis, costochondritis, myofascial syndrome
Limbs Complex regional pain syndrome, myofascial syndrome, frozen shoulder
Hernioplasty Traumatic neuritis
CHRONIC POSTOPERATIVE PAIN MECHANISMS
Chronic postoperative pain mechanisms are complex 
and not fully understood. Different mechanisms are 
responsible for different painful syndromes, even in a 
single type of surgery5.
There is the neuroplasticity process, which is complex 
and in constant change in membrane excitability, re-
ducing inhibitory mechanisms and increasing the ex-
citatory synaptic efficacy9. Surgical stimulation, which 
starts with the incision, is maintained throughout the 
postoperative inflammatory process and finishes only 
with surgical healing, causes the neuroplasticity pro-
cess6. There are two types of neuroplasticity: peripheral 
and central. Peripheral neuroplasticity is responsible 
for local hyperexcitability of high threshold peripheral 
nociceptive terminations and is caused by inflamma-
tory mediators released by injured tissues or inflam-
matory cells, by the activation of intracellular cascades 
with lower threshold and there may be pain percep-
tion with a weaker stimulation. In central neuroplas-
ticity there is synaptic change of the spinal cord with 
amplification of pain signal10. A peripheral nociceptive 
stimulation activates intracellular kinases pathway at 
the spinal cord dorsal horn changing ionic channels 
flow and the density of receptors and neurotransmit-
ters. Central sensitization increases activity and density 
of AMPA and NMDA receptors, leading to a post-syn-
aptic hyperexcitability. The increase of glutamater-
gic synapses in the spinal cord dorsal horn reinforces 
nociceptive stimulation transmission and recruits non-
nociceptive stimulations to the pain pathway. Kinase-C 
protein and nitric oxide (NO) activation contributes to 
increase the excitability of nociceptive neurons9. NO 
induces sensitization of nocireceptors, increasing pros-
taglandin E2 release, inhibiting the action of endogen 
antinociceptive substances on peripheral receptors and 
directly acting on nociceptors. Central sensitization is 
partially mediated by NMDA receptor activation with 
subsequent production of NO11. After central sensitiza-
tion induction, responsiveness of neurons is increased 
and even those which normally have ineffective syn-
apse for stimulations, inoculate and activate neuronal 
pain transmission10.
The mechanism of postoperative pain propagation by 
direct peripheral nervous injury is highly variable. The 
injury of major nerves located in the surgical field of 
most procedures is probably a pre-requisite for the 
development of CPOP10. In a thoracotomy study with 
and without intercostal nerve protection, pain evalua-
tion after 2 to 7 days has shown a lower pain score 
in patients who had their intercostal nerve protected, 
however this was not observed one month after sur-
gical procedure15. In a different study, authors carried 
out an electrophysiological study in patients submitted 
to thoracotomy before and three months after proced-
ure. They have not observed association between inter-
costal nerve injury and pain or sensitivity change after 
three months of follow-up13.
Risk factors
Several factors contribute to chronic postoperative 
pain14-17.
• Preoperative factors: pain lasting more than one month, 
psychological, genetic and diabetes mellitus;
• Intraoperative factors: nervous injury, incision site and 
type, duration, repeated surgery and complications;
• Postoperative factors: pain intensity, pain duration, im-
mobilization and inactivity.
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Risk factors for the development of CPOP are variable 
and may be individual and surgical. Most important fac-
tors are pain intensity and nervous injury. Other associ-
ated factors are: female gender and psychological fac-
tors (anxiety, depression, catastrofization, fear, passive 
behavior and secondary gain).
Age
Younger people run less risk of developing CPOP after 
thoracotomy18,19, breast cancer3 and elective abdominal20 
surgery.
Genetic 
It seems that changes in the GTP-cyclohydrolase 
gene, seen in approximately 15% of the population, 
is associated to protection against neuropathic pain 
and painful perception decrease. GTP-cyclohydrolase 
regulates tetrahydropiopterin production, which is 
an essential co-factor for the production of catechol-
amines, serotonin and nitric oxide, modulators of 
neuropathic and inflammatory pain21. There is a family 
history report on hypertension with decreased pain 
perception, which may be associated to mitochon-
drial DNA22, factor still very controversial23. Genetic 
polymorphism of catecholamine-O-methyltransferase 
gene is associated to the impact on pain perception 
and on the risk of developing CPOP24.
Perioperative pain
Severe pain immediately after surgery is a significant 
risk factor for CPOP. There are evidences that acute 
pain treatment not only accelerates surgical recov-
ery, but also decreases the risk for pain persistence25. 
Acute post C-section pain is an independent risk fac-
tor for the development of CPOP26. Pain after and be-
fore amputation is a significant predictor of chronic 
pain intensity, which suggests that the risk for post-
amputation chronic pain is higher in individuals with 
higher pain scores in all those moments27. Pain im-
mediately before amputation influences the develop-
ment of stump and phantom pain. However, a study 
has not associated acute pain to CPOP six months 
after total knee artroplasty28.
Psychosocial
Anxiety is a major factor for pain intensity. Anxious pa-
tients are in general hypersensitive to stimulation and 
psychologically more reactive. Depression is related 
to higher postoperative pain intensity, which makes us 
consider that the improvement of such symptoms and 
of postoperative pain may interrupt pain chronicity pro-
cess20. Fear of surgical consequences in the long run was 
associated to more pain, worse global recovery and qual-
ity of life; however optimism was associated to better 
recovery and quality of life29.
Surgical
Patients submitted to thoracotomy with different ac-
cess pathways and closure techniques have evolved 
differently18. Surgical procedures lasting more than 3 
hours are associated to increased risk for developing 
CPOP; however, longer surgeries are probably more 
complex and risky29. Change in inguinal sensitivity one 
year after surgery depends on the surgical technique19. 
Different techniques for different procedures evolve in 
different ways to CPOP. Video thoracoscopy poses a 
lower risk as compared to conventional thoracoscopy. 
Risk is higher for breast cancer surgery with axillary 
exploration2.
Prevention 
Prevention can be obtained as follows:
• Less traumatic surgery;
• Avoid nervous injury;





• Improvement of venous return;
• Avoid compressing structures.
Early and late postoperative pain prevention is a ma-
jor challenge for anesthesiologists and surgeons, since 
it is difficult to treat CPOP. In an attempt to improve 
its perioperative control and to estimate postopera-
tive pain, more and more studies are being developed 
every day to implement effective measures and to 
minimize unnecessary and inadequate surgeries3. Pos-
toperative pain is where the physician may influence 
the most3.
CPOP prevention should be performed not only by the 
anesthesiologist, but also by surgical teams. Patients sub-
mitted to surgical procedures should be aware of the risk 
of developing CPOP, since its incidence is high. Each 
elective surgical procedure should be carefully evaluat-
ed, analyzing benefits and risks. The surgical team shall 
know the different surgical techniques to which patients 
may be submitted, being able to choose, when possible, 
the technique exposing patients to the lowest risk of de-
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veloping CPOP. Carefully dissection of the surgical field 
avoiding nervous injuries and decreasing local inflam-
matory process and less invasive techniques may be 
strategies to prevent pain10.
A probability scale of the risk for developing CPOP 
was developed mentioning as some predictors age, 
gender, preoperative pain, type of surgery, incision 
size and level of anxiety, among others. It was valid-
ated for inpatients and outpatients and has good cor-
relation with the development of acute postoperative 
pain30. Since the presence of acute postoperative pain 
is associated to the risk of developing chronic pain, 
if we identify potential risk patients, more and more 
preventive measures, such as adequate and intensive 
treatment of pain throughout the perioperative period, 
may be performed to block CPOP development.
Treatment of pain
Treatment may be achieved with drugs, physical meas-
ures and blocks17. Drugs used are: anti-inflammatory 
drugs, paracetamol, dipirone, opioids, anticonvulsants, 
antidepressants, neuromuscular blocker, clonidine, 
ketamine and lidocaine. Several blocks may be per-
formed by epidural, intra-articular, in plexus, nerve or 
infiltration drug injection. Physical measures include: 
mobilization, kinesiotherapy, desensitization, active 
movements and orthesis.
Preventive analgesia may be induced, which is the treat-
ment started before surgery to prevent physical conse-
quences of nociceptive transmission to central neuro-
plasticity. Similar treatment, when used before surgery 
has potential to be more effective than after the begin-
ning of incision (preemptive analgesia)31.
Gabapentin and pregabalin are substances analog to 
GABA (gamma-aminobutyric acid) neurotransmitter, 
but do not bind to gabaergic receptors. Gabapentin-
oids bind to a sub-unit of voltage-dependent calcium 
channels of pre-synaptic neurons causing changes in 
the conformation with inhibition of abnormal neuronal 
activity, decreasing glutamate, norepinephrine, P sub-
stance and other neurotransmitters release, changing 
the neuroplasticity cascade. The prophylactic use of 
pregabalin decreases protein expression of calcium 
channel in the spinal cord, which is correlated to in-
creased nociception and allodynia 32. Gabapentin in 
single dose one hour before surgical procedure (her-
niorrhaphy and hysterectomy), decreased the risk and 
intensity of chronic pain in a 6-month follow-up33,34. It 
has also been observed that ketamine34 and gabapentin 
decreased postoperative opioid consumption33,35. A 
study with rats has shown that perineural lidocaine 
infiltration decreased neuropathic pain after sciatic 
nerve compression36.
A study evaluating three analgesic methods for pa-
tients submitted to thoracotomy has observed that pa-
tients with preoperative epidural block with bupiva-
caine and morphine presented less pain six months 
later as compared to patients with epidural block 
analgesia after the procedure and those with venous 
morphine analgesia37.
A metanalysis including randomized double-blind 
clinical trials of several surgical procedures about 
preemptive analgesia and evaluating acute and chron-
ic pain has observed that the use of venous non-hor-
monal opioid anti-inflammatory drugs and N-Methyl-
D-Aspartate receptors antagonists did not show pree-
mptive effects38.
It seems that multimodal analgesia with the association 
of drugs and techniques is more adequate to treat pain 
and decreases side effects. It should be done prevent-
ively and with enough duration to prevent central sensi-
tization by previous pain, surgical trauma and by pos-
toperative inflammation. However, adequate studies are 
needed for a better evaluation of chronic postoperative 
pain syndromes.
CONCLUSION
Chronic postoperative pain is a morbidity of high in-
cidence and affects quality of life of patients, although 
very often it is neglected by the medical team. CPOP 
is difficult to treat being prevention the most effective 
measure. With a better understanding of pathophysio-
logical bases for postoperative pain perpetuation and of 
risk factors, new options to treat pain are appearing. The 
real benefits of preventive drugs are being increasingly 
studied. To prevent pain, surgical teams and patients 
should be aware of the risks of each procedure, not only 
in the immediate postoperative period, but also in the 
long run.
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